A detailed history of Enterprise Financial Services Corp transactions in Novartis Ag stock. As of the latest transaction made, Enterprise Financial Services Corp holds 2,856 shares of NVS stock, worth $281,173. This represents 0.19% of its overall portfolio holdings.

Number of Shares
2,856
Previous 2,916 2.06%
Holding current value
$281,173
Previous $310,000 5.81%
% of portfolio
0.19%
Previous 0.19%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$106.13 - $120.89 $6,367 - $7,253
-60 Reduced 2.06%
2,856 $328,000
Q2 2024

Aug 13, 2024

SELL
$92.57 - $107.37 $32,214 - $37,364
-348 Reduced 10.66%
2,916 $310,000
Q1 2024

May 14, 2024

SELL
$95.27 - $108.47 $4,954 - $5,640
-52 Reduced 1.57%
3,264 $315,000
Q4 2023

Feb 09, 2024

BUY
$92.27 - $101.54 $16,793 - $18,480
182 Added 5.81%
3,316 $334,000
Q3 2023

Oct 31, 2023

BUY
$94.73 - $105.13 $3,315 - $3,679
35 Added 1.13%
3,134 $319,000
Q2 2023

Aug 11, 2023

SELL
$92.52 - $104.91 $6,939 - $7,868
-75 Reduced 2.36%
3,099 $312,000
Q1 2023

May 15, 2023

BUY
$80.03 - $92.81 $12,404 - $14,385
155 Added 5.13%
3,174 $292,000
Q4 2022

Feb 14, 2023

SELL
$75.55 - $92.52 $2,795 - $3,423
-37 Reduced 1.21%
3,019 $273,000
Q3 2022

Nov 14, 2022

SELL
$74.61 - $87.26 $4,327 - $5,061
-58 Reduced 1.86%
3,056 $232,000
Q2 2022

Aug 09, 2022

BUY
$80.52 - $93.75 $12,963 - $15,093
161 Added 5.45%
3,114 $263,000
Q1 2022

May 16, 2022

BUY
$80.11 - $90.62 $18,265 - $20,661
228 Added 8.37%
2,953 $259,000
Q4 2021

Feb 14, 2022

SELL
$79.7 - $88.13 $40,886 - $45,210
-513 Reduced 15.84%
2,725 $238,000
Q3 2021

Nov 15, 2021

BUY
$81.78 - $95.14 $42,607 - $49,567
521 Added 19.18%
3,238 $265,000
Q2 2021

Aug 16, 2021

SELL
$85.24 - $94.15 $36,823 - $40,672
-432 Reduced 13.72%
2,717 $247,000
Q1 2021

May 13, 2021

BUY
$83.5 - $98.47 $8,099 - $9,551
97 Added 3.18%
3,149 $269,000
Q4 2020

Feb 12, 2021

SELL
$78.07 - $94.43 $156 - $188
-2 Reduced 0.07%
3,052 $288,000
Q3 2020

Nov 13, 2020

SELL
$82.14 - $91.0 $22,917 - $25,389
-279 Reduced 8.37%
3,054 $266,000
Q2 2020

Aug 04, 2020

BUY
$80.93 - $91.1 $52,523 - $59,123
649 Added 24.18%
3,333 $291,000
Q1 2020

May 15, 2020

SELL
$70.67 - $99.01 $46,147 - $64,653
-653 Reduced 19.57%
2,684 $221,000
Q4 2019

Jan 28, 2020

BUY
$84.35 - $95.37 $49,513 - $55,982
587 Added 21.35%
3,337 $316,000
Q2 2019

Jul 30, 2019

BUY
$75.4 - $92.8 $3,543 - $4,361
47 Added 1.74%
2,750 $251,000
Q1 2019

Apr 26, 2019

BUY
$75.32 - $86.15 $9,264 - $10,596
123 Added 4.77%
2,703 $260,000
Q3 2018

Oct 26, 2018

SELL
$66.94 - $77.43 $10,308 - $11,924
-154 Reduced 5.63%
2,580 $222,000
Q2 2018

Jul 27, 2018

SELL
$64.91 - $73.36 $714 - $806
-11 Reduced 0.4%
2,734 $207,000
Q1 2018

Apr 27, 2018

BUY
$70.39 - $84.15 $11,684 - $13,968
166 Added 6.44%
2,745 $222,000
Q3 2017

Oct 27, 2017

BUY
$74.14 - $77.27 $191,207 - $199,279
2,579
2,579 $221,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Enterprise Financial Services Corp Portfolio

Follow Enterprise Financial Services Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Enterprise Financial Services Corp, based on Form 13F filings with the SEC.

News

Stay updated on Enterprise Financial Services Corp with notifications on news.